E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Standard · 3 min
[A new virus: the human herpesvirus 6].
Agut, H, Aubin, J T · La Revue du praticien · 1994
Quick Summary
Human herpesvirus 6 (HHV-6) is a virus discovered in 1986 that infects most people during childhood and stays in the body for life. It normally causes fever and rash in infants, but researchers have wondered whether it might play a role in chronic fatigue syndrome and other conditions, though this connection remains unclear. Some antiviral medications like ganciclovir appear to work against HHV-6 in laboratory tests.
Why It Matters
HHV-6 has long been suspected as a potential contributor to ME/CFS pathogenesis, making basic virology and epidemiological understanding important for researchers. This foundational review clarifies what was known about HHV-6 by the early 1990s and acknowledges the unresolved question of its role in chronic fatigue syndrome.
Observed Findings
HHV-6 infection is ubiquitous and occurs primarily during infancy
HHV-6 is the causative agent of exanthem subitum (roseola infantum) in infants
Two genetically and immunologically distinct HHV-6 variants exist (A and B)
HHV-6 has tropism for T lymphocytes and possibly epithelial cells
HHV-6 demonstrates in vitro sensitivity to ganciclovir and foscarnet
Inferred Conclusions
HHV-6 is a widespread human pathogen with lifelong latency after primary infection
HHV-6 may cause opportunistic infections in immunocompromised patients
The relationship between HHV-6 and ME/CFS requires further investigation and remains unresolved
Antiviral agents show laboratory promise against HHV-6 but clinical efficacy remains to be determined
Remaining Questions
What is the precise role of HHV-6 reactivation in ME/CFS pathogenesis, if any?
Do HHV-6 variants A and B differ in their association with chronic conditions?
What This Study Does Not Prove
This review does not establish that HHV-6 causes ME/CFS or even that it plays a significant role in the condition—the authors explicitly state this relationship is controversial and unproven. It does not present epidemiological comparisons between ME/CFS patients and controls, nor does it demonstrate causation or even consistent association in ME/CFS populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.